KIMBERLY MILLION: Open Payments
NPI 1871154401 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,136 in 69 payments from 23 companies in 2025. Trend: 2023 $773 · 2024 $1,277 · 2025 $1,136
Food & beverage: $1,136
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $229 |
| AstraZeneca Pharmaceuticals LP | 5 | $138 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Novo Nordisk Inc | 4 | $73 |
| Corium, LLC | 3 | $56 |
| Dexcom, Inc. | 3 | $53 |
| PFIZER INC. | 3 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| SANOFI-AVENTIS U.S. LLC | 1 | $40 |
Products named: VRAYLAR, BREZTRI, CAPLYTA, Wegovy, Auvelity, Azstarys, Dexcom G6 Transmitter, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
